Risk of Direct Oral Anticoagulant Bioaccumulation in Patients with Pulmonary Hypertension

Publisher： Karger

E-ISSN： 1423-0356|91|4|307-315

ISSN： 0025-7931

Source： Respiration, Vol.91, Iss.4, 2016-04, pp. : 307-315

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Assessment of Patients with Pulmonary Hypertension

By  

Respiration, Vol. 76, Iss. 4, 2008-11 ,pp. : 373-374

Karger

Access to resources Recommend Favorite

Treatment of Primary Pulmonary Hypertension with Oral Sildenafil

By  

Respiration, Vol. 71, Iss. 2, 2004-03 ,pp. : 192-194

Karger

Access to resources Recommend Favorite

D-Dimer Levels in Combination with Clinical Risk Factors Can Effectively Predict Subsequent Thromboembolic Events in Patients with Atrial Fibrillation during Oral Anticoagulant Therapy

By  

Cardiology, Vol. 117, Iss. 1, 2010-09 ,pp. : 31-36

Karger

Access to resources Recommend Favorite

Pulmonary Hypertension Risk in Patients with Hemoglobin H Disease: Low Incidence and Absence of Correlation with Splenectomy

By  

Acta Haematologica, Vol. 130, Iss. 3, 2013-05 ,pp. : 153-159

Karger

Access to resources Recommend Favorite

Characterization of Pulmonary Venous Hypertension Patients with Reactive Pulmonary Hypertension as Compared to Proportional Pulmonary Hypertension

By  

Respiration, Vol. 83, Iss. 6, 2011-08 ,pp. : 494-498

Karger

Access to resources Recommend Favorite